<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20071016/bs_nm/johnsonandjohnson_results_dc"><img src="http://d.yimg.com/us.yimg.com/p/nm/20071016/2007_10_16t084834_450x353_us_johnsonandjohnson_res ults.jpg?x=130&y=102&sig=F5aQ8lg2GDQFep54RkcR_Q--" align="left" height="102" width="130" alt="The Johnson and Johnson headquarters in New Brunswick, New Jersey in an undated file photo. Johnson and Johnson on Tuesday said third-quarter profit fell, hurt by restructuring charges and weak demand for its Procrit anemia drug, but the results handily beat Wall Street expectations. (Handout/Reuters)" border="0" /></a>Reuters - Johnson & Johnson on Tuesday
said third-quarter profit fell, hurt by restructuring charges
and weak demand for its Procrit anemia drug, but the results
handily beat Wall Street expectations.</p><br clear="all"/>

View the entire article: J&J third-quarter profit falls
(Reuters)